{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:42:25Z","timestamp":1794613345602,"version":"4.9.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011738","name":"Lee Kong Chian School of Medicine, Nanyang Technological University","doi-asserted-by":"publisher","award":["Dean's Postdoctoral Fellowship (Grant\/Award Number: 021207-00001)"],"award-info":[{"award-number":["Dean's Postdoctoral Fellowship (Grant\/Award Number: 021207-00001)"]}],"id":[{"id":"10.13039\/501100011738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019413","name":"Momental Foundation","doi-asserted-by":"publisher","award":["Mistletoe Research Fellowship (Grant Award Number 022522-00001)"],"award-info":[{"award-number":["Mistletoe Research Fellowship (Grant Award Number 022522-00001)"]}],"id":[{"id":"10.13039\/100019413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001475","name":"Nanyang Technological University","doi-asserted-by":"publisher","award":["Presidential Postdoctoral Fellowship (Grant\/Award Number: 021229-00001)"],"award-info":[{"award-number":["Presidential Postdoctoral Fellowship (Grant\/Award Number: 021229-00001)"]}],"id":[{"id":"10.13039\/501100001475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["Open Fund Young Investigator Research Grant (OF-YIRG) (Grant Award Number MOH-001147)"],"award-info":[{"award-number":["Open Fund Young Investigator Research Grant (OF-YIRG) (Grant Award Number MOH-001147)"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lysosomal acidification dysfunction has been implicated as a key driving factor in the pathogenesis of neurodegenerative diseases, including Alzheimer\u2019s disease and Parkinson\u2019s disease. Multiple genetic factors have been linked to lysosomal de-acidification through impairing the vacuolar-type ATPase and ion channels on the organelle membrane. Similar lysosomal abnormalities are also present in sporadic forms of neurodegeneration, although the underlying pathogenic mechanisms are unclear and remain to be investigated. Importantly, recent studies have revealed early occurrence of lysosomal acidification impairment before the onset of neurodegeneration and late-stage pathology. However, there is a lack of methods for organelle pH monitoring in vivo and a dearth of lysosome-acidifying therapeutic agents. Here, we summarize and present evidence for the notion of defective lysosomal acidification as an early indicator of neurodegeneration and urge the critical need for technological advancement in developing tools for lysosomal pH monitoring and detection both in vivo and for clinical applications. We further discuss current preclinical pharmacological agents that modulate lysosomal acidification, including small molecules and nanomedicine, and their potential clinical translation into lysosome-targeting therapies. Both timely detection of lysosomal dysfunction and development of therapeutics that restore lysosomal function represent paradigm shifts in targeting neurodegenerative diseases.<\/jats:p>","DOI":"10.1186\/s40035-023-00362-0","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T20:01:42Z","timestamp":1686168102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases"],"prefix":"10.1186","volume":"12","author":[{"given":"Chih Hung","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-1432","authenticated-orcid":false,"given":"Jialiu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"3","key":"362_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.tins.2021.12.004","volume":"45","author":"V Udayar","year":"2022","unstructured":"Udayar V, Chen Y, Sidransky E, Jagasia R. Lysosomal dysfunction in neurodegeneration: emerging concepts and methods. Trends Neurosci. 2022;45(3):184\u201399.","journal-title":"Trends Neurosci"},{"issue":"12","key":"362_CR2","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","volume":"18","author":"SR Bonam","year":"2019","unstructured":"Bonam SR, Wang F, Muller S. Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019;18(12):923\u201348.","journal-title":"Nat Rev Drug Discov"},{"key":"362_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fcell.2019.00113","volume":"7","author":"S Inpanathan","year":"2019","unstructured":"Inpanathan S, Botelho RJ. The lysosome signaling platform: adapting with the times. Front Cell Dev Biol. 2019;7:113.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"362_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","volume":"21","author":"RE Lawrence","year":"2019","unstructured":"Lawrence RE, Zoncu R. The lysosome as a cellular centre for signalling, metabolism and quality control. Nat Cell Biol. 2019;21(2):133\u201342.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"362_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-physiol-012110-142317","volume":"74","author":"JA Mindell","year":"2012","unstructured":"Mindell JA. Lysosomal acidification mechanisms. Annu Rev Physiol. 2012;74(1):69\u201386.","journal-title":"Annu Rev Physiol"},{"key":"362_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.arr.2016.04.010","volume":"32","author":"V Stoka","year":"2016","unstructured":"Stoka V, Turk V, Turk B. Lysosomal cathepsins and their regulation in aging and neurodegeneration. Ageing Res Rev. 2016;32:22\u201337.","journal-title":"Ageing Res Rev"},{"key":"362_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.arr.2016.05.004","volume":"32","author":"DJ Colacurcio","year":"2016","unstructured":"Colacurcio DJ, Nixon RA. Disorders of lysosomal acidification\u2014the emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res Rev. 2016;32:75\u201388.","journal-title":"Ageing Res Rev"},{"issue":"7","key":"362_CR8","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1096\/fj.201700359","volume":"31","author":"RA Nixon","year":"2017","unstructured":"Nixon RA. Amyloid precursor protein and endosomal\u2013lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease. FASEB J. 2017;31(7):2729\u201343.","journal-title":"FASEB J"},{"issue":"9","key":"362_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrd.2018.109","volume":"17","author":"B Boland","year":"2018","unstructured":"Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018;17(9):660\u201388.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"362_CR10","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","volume":"141","author":"J-H Lee","year":"2010","unstructured":"Lee J-H, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell. 2010;141(7):1146\u201358.","journal-title":"Cell"},{"issue":"9","key":"362_CR11","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.celrep.2015.07.050","volume":"12","author":"J-H Lee","year":"2015","unstructured":"Lee J-H, McBrayer MK, Wolfe DM, Haslett LJ, Kumar A, Sato Y, et al. Presenilin 1 maintains lysosomal ca(2+) Homeostasis via TRPML1 by regulating vATPase-Mediated lysosome acidification. Cell Rep. 2015;12(9):1430\u201344.","journal-title":"Cell Rep"},{"issue":"6","key":"362_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","volume":"25","author":"J-H Lee","year":"2022","unstructured":"Lee J-H, Yang D-S, Goulbourne CN, Im E, Stavrides P, Pensalfini A, et al. Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of A\u03b2 in neurons, yielding senile plaques. Nat Neurosci. 2022;25(6):688\u2013701.","journal-title":"Nat Neurosci"},{"issue":"27","key":"362_CR13","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1523\/JNEUROSCI.0578-19.2019","volume":"39","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Sato Y, Im E, Berg M, Bordi M, Darji S, et al. Lysosomal dysfunction in Down syndrome is APP-dependent and mediated by APP-\u03b2CTF (C99). J Neurosci. 2019;39(27):5255\u201368.","journal-title":"J Neurosci"},{"key":"362_CR14","doi-asserted-by":"publisher","unstructured":"Im E, Jiang Y, Stavrides P, Darji S, Erdjument-Bromage H, Neubert TA et al. Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by selective v-ATPase inhibition by Tyr682 phosphorylated APP \u03b2CTF. bioRxiv. https:\/\/doi.org\/10.1101\/2022.06.02.494546.","DOI":"10.1101\/2022.06.02.494546"},{"issue":"25","key":"362_CR15","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.1523\/JNEUROSCI.0556-12.2012","volume":"32","author":"X Zhang","year":"2012","unstructured":"Zhang X, Garbett K, Veeraraghavalu K, Wilburn B, Gilmore R, Mirnics K, et al. A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J Neurosci. 2012;32(25):8633\u201348.","journal-title":"J Neurosci"},{"issue":"8","key":"362_CR16","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1080\/15548627.2019.1609863","volume":"15","author":"M \u015eent\u00fcrk","year":"2019","unstructured":"\u015eent\u00fcrk M, Mao D, Bellen HJ. Loss of proteins associated with amyotrophic lateral sclerosis affects lysosomal acidification via different routes. Autophagy. 2019;15(8):1467\u20139.","journal-title":"Autophagy"},{"key":"362_CR17","doi-asserted-by":"publisher","first-page":"105360","DOI":"10.1016\/j.nbd.2021.105360","volume":"154","author":"J Root","year":"2021","unstructured":"Root J, Merino P, Nuckols A, Johnson M, Kukar T. Lysosome dysfunction as a cause of neurodegenerative diseases: lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;154:105360.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"362_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.stemcr.2018.06.022","volume":"11","author":"A Verheyen","year":"2018","unstructured":"Verheyen A, Diels A, Reumers J, Van Hoorde K, Van den Wyngaert I, van Outryve d\u2019Ydewalle C, et al. Genetically engineered iPSC-Derived FTDP-17 MAPT neurons display mutation-specific neurodegenerative and neurodevelopmental phenotypes. Stem Cell Rep. 2018;11(2):363\u201379.","journal-title":"Stem Cell Rep"},{"key":"362_CR19","doi-asserted-by":"crossref","unstructured":"Kim SH, Cho YS, Kim Y, Park J, Yoo SM, Gwak J, et al. Endolysosomal impairment by binding of amyloid beta or MAPT\/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease. Autophagy. 2023;1\u201320.","DOI":"10.1080\/15548627.2023.2181614"},{"issue":"1","key":"362_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12929-022-00871-6","volume":"29","author":"BC-K Tong","year":"2022","unstructured":"Tong BC-K, Huang AS, Wu AJ, Iyaswamy A, Ho OK-Y, Kong AH-Y, et al. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies. J Biomed Sci. 2022;29(1):85.","journal-title":"J Biomed Sci"},{"issue":"5","key":"362_CR21","doi-asserted-by":"publisher","first-page":"e62459","DOI":"10.1371\/journal.pone.0062459","volume":"8","author":"S Ozcelik","year":"2013","unstructured":"Ozcelik S, Fraser G, Castets P, Schaeffer V, Skachokova Z, Breu K, et al. Rapamycin attenuates the Progression of Tau Pathology in P301S Tau Transgenic mice. PLoS ONE. 2013;8(5):e62459.","journal-title":"PLoS ONE"},{"issue":"4","key":"362_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.4161\/auto.19048","volume":"8","author":"EE Congdon","year":"2012","unstructured":"Congdon EE, Wu JW, Myeku N, Figueroa YH, Herman M, Marinec PS, et al. Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy. 2012;8(4):609\u201322.","journal-title":"Autophagy"},{"issue":"10","key":"362_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/mds.23085","volume":"25","author":"P Poorkaj","year":"2010","unstructured":"Poorkaj P, Raskind WH, Leverenz JB, Matsushita M, Zabetian CP, Samii A, et al. A novel X-linked four-repeat tauopathy with parkinsonism and spasticity. Mov Disord. 2010;25(10):1409\u201317.","journal-title":"Mov Disord"},{"issue":"16","key":"362_CR24","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/hmg\/ddz088","volume":"28","author":"R Wallings","year":"2019","unstructured":"Wallings R, Connor-Robson N, Wade-Martins R. LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function. Hum Mol Genet. 2019;28(16):2696\u2013710.","journal-title":"Hum Mol Genet"},{"issue":"7795","key":"362_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41586-020-1968-7","volume":"578","author":"S van Veen","year":"2020","unstructured":"van Veen S, Martin S, van den Haute C, Benoy V, Lyons J, Vanhoutte R, et al. ATP13A2 deficiency disrupts lysosomal polyamine export. Nature. 2020;578(7795):419\u201324.","journal-title":"Nature"},{"issue":"6","key":"362_CR26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00401-020-02145-7","volume":"139","author":"S Martin","year":"2020","unstructured":"Martin S, Smolders S, van den Haute C, Heeman B, van Veen S, Crosiers D, et al. Mutated ATP10B increases Parkinson\u2019s disease risk by compromising lysosomal glucosylceramide export. Acta Neuropathol. 2020;139(6):1001\u201324.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"362_CR27","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s11064-020-03126-8","volume":"45","author":"AC Nascimento","year":"2020","unstructured":"Nascimento AC, Erustes AG, Reckziegel P, Bincoletto C, Ureshino RP, Pereira GJS, et al. \u03b1-Synuclein overexpression induces lysosomal dysfunction and autophagy impairment in human neuroblastoma SH-SY5Y. Neurochem Res. 2020;45(11):2749\u201361.","journal-title":"Neurochem Res"},{"issue":"9","key":"362_CR28","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1073\/pnas.1616332114","volume":"114","author":"S Jinn","year":"2017","unstructured":"Jinn S, Drolet RE, Cramer PE, Wong AH-K, Toolan DM, Gretzula CA, et al. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases \u03b1-synuclein aggregation. Proc Natl Acad Sci U S A. 2017;114(9):2389\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"362_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cell.2015.08.002","volume":"162","author":"C Cang","year":"2015","unstructured":"Cang C, Aranda K, Seo Y, Gasnier B, Ren D. TMEM175 is an organelle K+ channel regulating lysosomal function. Cell. 2015;162(5):1101\u201312.","journal-title":"Cell"},{"issue":"3","key":"362_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/15548627.2015.1136769","volume":"12","author":"M Bourdenx","year":"2016","unstructured":"Bourdenx M, Daniel J, Genin E, Soria FN, Blanchard-Desce M, Bezard E, et al. Nanoparticles restore lysosomal acidification defects: implications for Parkinson and other lysosomal-related diseases. Autophagy. 2016;12(3):472\u201383.","journal-title":"Autophagy"},{"issue":"31","key":"362_CR31","doi-asserted-by":"publisher","first-page":"13910","DOI":"10.1021\/acs.iecr.9b02003","volume":"58","author":"J Zeng","year":"2019","unstructured":"Zeng J, Martin A, Han X, Shirihai OS, Grinstaff MW. Biodegradable PLGA nanoparticles restore lysosomal acidity and protect neural PC-12 cells against mitochondrial toxicity. Ind Eng Chem Res. 2019;58(31):13910\u20137.","journal-title":"Ind Eng Chem Res"},{"issue":"4","key":"362_CR32","doi-asserted-by":"publisher","first-page":"e13584","DOI":"10.1111\/acel.13584","volume":"21","author":"M-L Arotcarena","year":"2022","unstructured":"Arotcarena M-L, Soria FN, Cunha A, Doudnikoff E, Pr\u00e9vot G, Daniel J, et al. Acidic nanoparticles protect against \u03b1-synuclein-induced neurodegeneration through the restoration of lysosomal function. Aging Cell. 2022;21(4):e13584.","journal-title":"Aging Cell"},{"issue":"Suppl 2","key":"362_CR33","first-page":"81","volume":"9","author":"RU Onyenwoke","year":"2015","unstructured":"Onyenwoke RU, Brenman JE. Lysosomal storage diseases-regulating neurodegeneration. J Exp Neurosci. 2015;9(Suppl 2):81\u201391.","journal-title":"J Exp Neurosci"},{"key":"362_CR34","doi-asserted-by":"publisher","first-page":"107851","DOI":"10.1016\/j.neuropharm.2019.107851","volume":"171","author":"A Toledano-Zaragoza","year":"2020","unstructured":"Toledano-Zaragoza A, Ledesma MD. Addressing neurodegeneration in lysosomal storage disorders: advances in Niemann pick diseases. Neuropharmacology. 2020;171:107851.","journal-title":"Neuropharmacology"},{"key":"362_CR35","doi-asserted-by":"publisher","first-page":"102553","DOI":"10.1016\/j.ceca.2022.102553","volume":"103","author":"E Krogsaeter","year":"2022","unstructured":"Krogsaeter E, Rosato AS, Grimm C. TRPMLs and TPCs: targets for lysosomal storage and neurodegenerative disease therapy? Cell Calcium. 2022;103:102553.","journal-title":"Cell Calcium"},{"issue":"7428","key":"362_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature11654","volume":"492","author":"AL Hughes","year":"2012","unstructured":"Hughes AL, Gottschling DE. An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast. Nature. 2012;492(7428):261\u20135.","journal-title":"Nature"},{"issue":"5","key":"362_CR37","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1083\/jcb.201003062","volume":"189","author":"WR Williamson","year":"2010","unstructured":"Williamson WR, Wang D, Haberman AS, Hiesinger PR. A dual function of V0-ATPase a1 provides an endolysosomal degradation mechanism in Drosophila melanogaster photoreceptors. J Cell Biol. 2010;189(5):885\u201399.","journal-title":"J Cell Biol"},{"issue":"23","key":"362_CR38","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.1093\/hmg\/ddv380","volume":"24","author":"A Dubos","year":"2015","unstructured":"Dubos A, Castells-Nobau A, Meziane H, Oortveld MAW, Houbaert X, Iacono G, et al. Conditional depletion of intellectual disability and parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and neurodegeneration. Hum Mol Genet. 2015;24(23):6736\u201355.","journal-title":"Hum Mol Genet"},{"issue":"16","key":"362_CR39","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1093\/hmg\/ddt180","volume":"22","author":"O Korvatska","year":"2013","unstructured":"Korvatska O, Strand NS, Berndt JD, Strovas T, Chen D-H, Leverenz JB, et al. Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS). Hum Mol Genet. 2013;22(16):3259\u201368.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"362_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000;157(1):277\u201386.","journal-title":"Am J Pathol"},{"issue":"9","key":"362_CR41","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/awab467","volume":"145","author":"Y Lee","year":"2022","unstructured":"Lee Y, Miller MR, Fernandez MA, Berg EL, Prada AM, Ouyang Q, et al. Early lysosome defects precede neurodegeneration with amyloid-\u03b2 and tau aggregation in NHE6-null rat brain. Brain. 2022;145(9):3187\u2013202.","journal-title":"Brain"},{"issue":"9","key":"362_CR42","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awaa223","volume":"143","author":"E Drummond","year":"2020","unstructured":"Drummond E, Pires G, MacMurray C, Askenazi M, Nayak S, Bourdon M, et al. Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain. Brain. 2020;143(9):2803\u201317.","journal-title":"Brain"},{"issue":"3","key":"362_CR43","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3233\/JAD-160307","volume":"53","author":"SK Woody","year":"2016","unstructured":"Woody SK, Zhou H, Ibrahimi S, Dong Y, Zhao L. Human ApoE \u025b2 promotes regulatory mechanisms of bioenergetic and synaptic function in female brain: a focus on V-type H+-ATPase. J Alzheimers Dis. 2016;53(3):1015\u201331.","journal-title":"J Alzheimers Dis"},{"key":"362_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ibror.2016.09.001","volume":"1","author":"RS Chaves","year":"2016","unstructured":"Chaves RS, Kazi AI, Silva CM, Almeida MF, Lima RS, Carrettiero DC, et al. Presence of insoluble tau following rotenone exposure ameliorates basic pathways associated with neurodegeneration. IBRO Rep. 2016;1:32\u201345.","journal-title":"IBRO Rep"},{"key":"362_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-016-0292-9","volume":"4","author":"A Piras","year":"2016","unstructured":"Piras A, Collin L, Gr\u00fcninger F, Graff C, R\u00f6nnb\u00e4ck A. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol Commun. 2016;4:22.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"362_CR46","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/mds.25462","volume":"28","author":"B Dehay","year":"2013","unstructured":"Dehay B, Martinez-Vicente M, Caldwell GA, Caldwell KA, Yue Z, Cookson MR, et al. Lysosomal impairment in Parkinson\u2019s disease. Mov Disord. 2013;28(6):725\u201332.","journal-title":"Mov Disord"},{"key":"362_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.arr.2016.02.008","volume":"32","author":"M Bourdenx","year":"2016","unstructured":"Bourdenx M, Dehay B. What lysosomes actually tell us about Parkinson\u2019s disease? Ageing Res Rev. 2016;32:140\u20139.","journal-title":"Ageing Res Rev"},{"issue":"24","key":"362_CR48","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1073\/pnas.1112368109","volume":"109","author":"B Dehay","year":"2012","unstructured":"Dehay B, Ramirez A, Martinez-Vicente M, Perier C, Canron M-H, Doudnikoff E, et al. Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc Natl Acad Sci U S A. 2012;109(24):9611\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"362_CR49","doi-asserted-by":"publisher","first-page":"11803","DOI":"10.1038\/ncomms11803","volume":"7","author":"CF Bento","year":"2016","unstructured":"Bento CF, Ashkenazi A, Jimenez-Sanchez M, Rubinsztein DC. The Parkinson\u2019s disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway. Nat Commun. 2016;7(1):11803.","journal-title":"Nat Commun"},{"issue":"1","key":"362_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1083\/jcb.201804165","volume":"218","author":"R Wang","year":"2018","unstructured":"Wang R, Tan J, Chen T, Han H, Tian R, Tan Y, et al. ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome\u2013lysosome fusion. J Cell Biol. 2018;218(1):267\u201384.","journal-title":"J Cell Biol"},{"issue":"10","key":"362_CR51","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","volume":"22","author":"PJ Schultheis","year":"2013","unstructured":"Schultheis PJ, Fleming SM, Clippinger AK, Lewis J, Tsunemi T, Giasson B, et al. Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited \u03b1-synuclein accumulation and age-dependent sensorimotor deficits. Hum Mol Genet. 2013;22(10):2067\u201382.","journal-title":"Hum Mol Genet"},{"issue":"21","key":"362_CR52","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1093\/hmg\/ddv314","volume":"24","author":"AG Henry","year":"2015","unstructured":"Henry AG, Aghamohammadzadeh S, Samaroo H, Chen Y, Mou K, Needle E, et al. Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression. Hum Mol Genet. 2015;24(21):6013\u201328.","journal-title":"Hum Mol Genet"},{"issue":"37","key":"362_CR53","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","volume":"30","author":"B Dehay","year":"2010","unstructured":"Dehay B, Bove J, Rodriguez-Muela N, Perier C, Recasens A, Boya P, et al. Pathogenic lysosomal depletion in Parkinson\u2019s disease. J Neurosci. 2010;30(37):12535\u201344.","journal-title":"J Neurosci"},{"issue":"12","key":"362_CR54","doi-asserted-by":"publisher","first-page":"e49635","DOI":"10.1371\/journal.pone.0049635","volume":"7","author":"GC Baltazar","year":"2012","unstructured":"Baltazar GC, Guha S, Lu W, Lim J, Boesze-Battaglia K, Laties AM, et al. Acidic nanoparticles are trafficked to lysosomes and restore an acidic lysosomal pH and degradative function to compromised ARPE-19 cells. PLoS ONE. 2012;7(12):e49635.","journal-title":"PLoS ONE"},{"issue":"6","key":"362_CR55","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1021\/acssensors.0c02318","volume":"6","author":"MY Chin","year":"2021","unstructured":"Chin MY, Patwardhan AR, Ang K-H, Wang AL, Alquezar C, Welch M, et al. Genetically encoded, pH-Sensitive mTFP1 Biosensor for probing lysosomal pH. ACS Sens. 2021;6(6):2168\u201380.","journal-title":"ACS Sens"},{"issue":"1","key":"362_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.52601\/bpr.2021.200047","volume":"7","author":"X Li","year":"2021","unstructured":"Li X, Sun Y, Wang X. Probing lysosomal activity in vivo. Biophys Rep. 2021;7(1):1\u20137.","journal-title":"Biophys Rep"},{"key":"362_CR57","doi-asserted-by":"publisher","first-page":"e55745","DOI":"10.7554\/eLife.55745","volume":"9","author":"Y Sun","year":"2020","unstructured":"Sun Y, Li M, Zhao D, Li X, Yang C, Wang X. Lysosome activity is modulated by multiple longevity pathways and is important for lifespan extension in C. elegans. Elife. 2020;9:e55745.","journal-title":"Elife"},{"issue":"3","key":"362_CR58","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/15548627.2018.1528812","volume":"15","author":"J-H Lee","year":"2019","unstructured":"Lee J-H, Rao MV, Yang D-S, Stavrides P, Im E, Pensalfini A, et al. Transgenic expression of a ratiometric autophagy probe specifically in neurons enables the interrogation of brain autophagy in vivo. Autophagy. 2019;15(3):543\u201357.","journal-title":"Autophagy"},{"key":"362_CR59","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuroscience.2014.01.001","volume":"263","author":"EE Coffey","year":"2014","unstructured":"Coffey EE, Beckel JM, Laties AM, Mitchell CH. Lysosomal alkalization and dysfunction in human fibroblasts with the alzheimer\u2019s disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience. 2014;263:111\u201324.","journal-title":"Neuroscience"},{"issue":"6","key":"362_CR60","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1073\/pnas.1014641108","volume":"108","author":"P Kannan","year":"2011","unstructured":"Kannan P, Brimacombe KR, Kreisl WC, Liow J-S, Zoghbi SS, Telu S, et al. Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET. Proc Natl Acad Sci U S A. 2011;108(6):2593\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"362_CR61","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00259-019-04488-0","volume":"47","author":"SP McCluskey","year":"2020","unstructured":"McCluskey SP, Plisson C, Rabiner EA, Howes O. Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development. Eur J Nucl Med Mol Imaging. 2020;47(2):451\u201389.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"362_CR62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","volume":"30","author":"VW Pike","year":"2009","unstructured":"Pike VW. PET radiotracers: crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol Sci. 2009;30(8):431\u201340.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"362_CR63","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3390\/cells9071679","volume":"9","author":"T Yadati","year":"2020","unstructured":"Yadati T, Houben T, Bitorina A, Shiri-Sverdlov R. The ins and outs of cathepsins: physiological function and role in disease management. Cells. 2020;9(7):1679.","journal-title":"Cells"},{"issue":"7","key":"362_CR64","doi-asserted-by":"publisher","first-page":"119243","DOI":"10.1016\/j.bbamcr.2022.119243","volume":"1869","author":"A Drobny","year":"2022","unstructured":"Drobny A, Prieto Huarcaya S, Dobert J, Kluge A, Bunk J, Schlothauer T, et al. The role of lysosomal cathepsins in neurodegeneration: mechanistic insights, diagnostic potential and therapeutic approaches. Biochim Biophys Acta Mol Cell Res. 2022;1869(7):119243.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"8","key":"362_CR65","doi-asserted-by":"publisher","first-page":"140428","DOI":"10.1016\/j.bbapap.2020.140428","volume":"1868","author":"V Hook","year":"2020","unstructured":"Hook V, Yoon M, Mosier C, Ito G, Podvin S, Head BP, et al. Cathepsin B in neurodegeneration of Alzheimer\u2019s disease, traumatic brain injury, and related brain disorders. Biochim Biophys Acta Proteins Proteom. 2020;1868(8):140428.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"issue":"1","key":"362_CR66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","volume":"85","author":"EJ Goetzl","year":"2015","unstructured":"Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, et al. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology. 2015;85(1):40\u20137.","journal-title":"Neurology"},{"issue":"1","key":"362_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bpa.12631","volume":"29","author":"YL Chai","year":"2019","unstructured":"Chai YL, Chong JR, Weng J, Howlett D, Halsey A, Lee JH, et al. Lysosomal cathepsin D is upregulated in Alzheimer\u2019s disease neocortex and may be a marker for neurofibrillary degeneration. Brain Pathol. 2019;29(1):63\u201374.","journal-title":"Brain Pathol"},{"issue":"3","key":"362_CR68","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0896-6273(95)90324-0","volume":"14","author":"AM Cataldo","year":"1995","unstructured":"Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S, et al. Gene expression and cellular content of cathepsin D in Alzheimer\u2019s disease brain: evidence for early up-regulation of the endosomal\u2013lysosomal system. Neuron. 1995;14(3):671\u201380.","journal-title":"Neuron"},{"issue":"1","key":"362_CR69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13195-019-0533-9","volume":"11","author":"S Sj\u00f6din","year":"2019","unstructured":"Sj\u00f6din S, Brinkmalm G, \u00d6hrfelt A, Parnetti L, Paciotti S, Hansson O, et al. Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer\u2019s and Parkinson\u2019s disease. Alzheimers Res Ther. 2019;11(1):82.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"362_CR70","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s12035-018-1090-0","volume":"56","author":"TE Moors","year":"2019","unstructured":"Moors TE, Paciotti S, Ingrassia A, Quadri M, Breedveld G, Tasegian A, et al. Characterization of Brain lysosomal activities in GBA-Related and sporadic Parkinson\u2019s disease and dementia with lewy bodies. Mol Neurobiol. 2019;56(2):1344\u201355.","journal-title":"Mol Neurobiol"},{"key":"362_CR71","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fimmu.2019.00578","volume":"10","author":"VM Harris","year":"2019","unstructured":"Harris VM, Harley ITW, Kurien BT, Koelsch KA, Scofield RH. Lysosomal pH is regulated in a sex dependent manner in Immune cells expressing CXorf21. Front Immunol. 2019;10:578.","journal-title":"Front Immunol"},{"key":"362_CR72","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnmol.2020.00038","volume":"13","author":"S Hornung","year":"2020","unstructured":"Hornung S, Dutta S, Bitan G. CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci. 2020;13:38.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"362_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9(1):19.","journal-title":"Cell Biosci"},{"issue":"8","key":"362_CR74","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1016\/j.jmb.2020.02.023","volume":"432","author":"SN Suresh","year":"2020","unstructured":"Suresh SN, Chakravorty A, Giridharan M, Garimella L, Manjithaya R. Pharmacological tools to modulate autophagy in neurodegenerative diseases. J Mol Biol. 2020;432(8):2822\u201342.","journal-title":"J Mol Biol"},{"issue":"10","key":"362_CR75","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1021\/acschemneuro.1c00804","volume":"13","author":"MY Chin","year":"2022","unstructured":"Chin MY, Ang K-H, Davies J, Alquezar C, Garda VG, Rooney B, et al. Phenotypic screening using high-content imaging to identify lysosomal pH modulators in a neuronal cell model. ACS Chem Neurosci. 2022;13(10):1505\u201316.","journal-title":"ACS Chem Neurosci"},{"issue":"11","key":"362_CR76","doi-asserted-by":"publisher","first-page":"e2121609119","DOI":"10.1073\/pnas.2121609119","volume":"119","author":"RT Vest","year":"2022","unstructured":"Vest RT, Chou C-C, Zhang H, Haney MS, Li L, Laqtom NN, et al. Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration. Proc Natl Acad Sci U S A. 2022;119(11):e2121609119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"362_CR77","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41589-019-0308-4","volume":"15","author":"CY-S Chung","year":"2019","unstructured":"Chung CY-S, Shin HR, Berdan CA, Ford B, Ward CC, Olzmann JA, et al. Covalent targeting of the vacuolar H(+)-ATPase activates autophagy via mTORC1 inhibition. Nat Chem Biol. 2019;15(8):776\u201385.","journal-title":"Nat Chem Biol"},{"issue":"32","key":"362_CR78","doi-asserted-by":"publisher","first-page":"24676","DOI":"10.1074\/jbc.M110.106278","volume":"285","author":"R Alzamora","year":"2010","unstructured":"Alzamora R, Thali RF, Gong F, Smolak C, Li H, Baty CJ, et al. PKA regulates vacuolar H+-ATPase localization and activity via direct phosphorylation of the a subunit in kidney cells. J Biol Chem. 2010;285(32):24676\u201385.","journal-title":"J Biol Chem"},{"issue":"4","key":"362_CR79","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1091\/mbc.e06-10-0975","volume":"18","author":"A Majumdar","year":"2007","unstructured":"Majumdar A, Cruz D, Asamoah N, Buxbaum A, Sohar I, Lobel P, et al. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol Biol Cell. 2007;18(4):1490\u20136.","journal-title":"Mol Biol Cell"},{"issue":"4","key":"362_CR80","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1085\/jgp.201611606","volume":"148","author":"N Rahman","year":"2016","unstructured":"Rahman N, Ramos-Espiritu L, Milner TA, Buck J, Levin LR. Soluble adenylyl cyclase is essential for proper lysosomal acidification. J Gen Physiol. 2016;148(4):325\u201339.","journal-title":"J Gen Physiol"},{"issue":"1","key":"362_CR81","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1038\/ncomms5681","volume":"5","author":"C-C Chen","year":"2014","unstructured":"Chen C-C, Keller M, Hess M, Schiffmann R, Urban N, Wolfgardt A, et al. A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV. Nat Commun. 2014;5(1):4681.","journal-title":"Nat Commun"},{"issue":"1","key":"362_CR82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/tra.12620","volume":"20","author":"XC Yao","year":"2019","unstructured":"Yao XC, Xue X, Zhang HT, Zhu MM, Yang XW, Wu CF, et al. Pseudoginsenoside-F11 alleviates oligomeric \u03b2-amyloid-induced endosome-lysosome defects in microglia. Traffic. 2019;20(1):61\u201370.","journal-title":"Traffic"},{"issue":"4","key":"362_CR83","first-page":"25","volume":"2","author":"J Zeng","year":"2020","unstructured":"Zeng J, Shirihai OS, Grinstaff MW. Modulating lysosomal pH: a molecular and nanoscale materials design perspective. J Life Sci (Westlake Village). 2020;2(4):25\u201337.","journal-title":"J Life Sci (Westlake Village)"},{"key":"362_CR84","doi-asserted-by":"publisher","first-page":"736554","DOI":"10.3389\/fchem.2021.736554","volume":"9","author":"M Brouillard","year":"2021","unstructured":"Brouillard M, Barth\u00e9l\u00e9my P, Dehay B, Crauste-Manciet S, Desvergnes V. Nucleolipid acid-based nanocarriers restore neuronal lysosomal acidification defects. Front Chem. 2021;9:736554.","journal-title":"Front Chem"},{"issue":"7","key":"362_CR85","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/pharmaceutics13071042","volume":"13","author":"A Cunha","year":"2021","unstructured":"Cunha A, Gaubert A, Latxague L, Dehay B. PLGA-Based nanoparticles for neuroprotective drug delivery in neurodegenerative diseases. Pharmaceutics. 2021;13(7):1042.","journal-title":"Pharmaceutics"},{"issue":"1","key":"362_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1083\/jcb.201511042","volume":"214","author":"KM Trudeau","year":"2016","unstructured":"Trudeau KM, Colby AH, Zeng J, Las G, Feng JH, Grinstaff MW, et al. Lysosome acidification by photoactivated nanoparticles restores autophagy under lipotoxicity. J Cell Biol. 2016;214(1):25\u201334.","journal-title":"J Cell Biol"},{"issue":"1","key":"362_CR87","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1038\/s41467-023-38165-6","volume":"14","author":"J Zeng","year":"2023","unstructured":"Zeng J, Acin-Perez R, Assali EA, Andrew M, Brownstein A, Petcherski A, et al. Restoration of lysosomal acidification using acidic nanoparticles to rescue autophagy and metabolic dysfunction in non-alcoholic fatty liver disease. Nat Commun. 2023;14(1):2573.","journal-title":"Nat Commun"},{"key":"362_CR88","unstructured":"Shirihai OS, Grinstaff MW, Zeng J. Acidic nanoparticles for restoration of autophagy. 2022. US Patent App 17\/744,527."},{"issue":"12","key":"362_CR89","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1021\/acs.bioconjchem.8b00697","volume":"29","author":"G Prevot","year":"2018","unstructured":"Prevot G, Soria FN, Thiolat M-L, Daniel J, Verlhac JB, Blanchard-Desce M, et al. Harnessing lysosomal pH through PLGA Nanoemulsion as a treatment of lysosomal-related neurodegenerative Diseases. Bioconjug Chem. 2018;29(12):4083\u20139.","journal-title":"Bioconjug Chem"},{"key":"362_CR90","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bioactmat.2022.05.030","volume":"17","author":"B Anand","year":"2022","unstructured":"Anand B, Wu Q, Nakhaei-Nejad M, Karthivashan G, Dorosh L, Amidian S, et al. Significance of native PLGA nanoparticles in the treatment of Alzheimer\u2019s disease pathology. Bioact Mater. 2022;17:506\u201325.","journal-title":"Bioact Mater"},{"issue":"3","key":"362_CR91","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41556-019-0281-x","volume":"21","author":"M \u015eent\u00fcrk","year":"2019","unstructured":"\u015eent\u00fcrk M, Lin G, Zuo Z, Mao D, Watson E, Mikos AG, et al. Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat Cell Biol. 2019;21(3):384\u201396.","journal-title":"Nat Cell Biol"},{"key":"362_CR92","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","volume":"304","author":"K Park","year":"2019","unstructured":"Park K, Skidmore S, Hadar J, Garner J, Park H, Otte A, et al. Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation. J Control Release. 2019;304:125\u201334.","journal-title":"J Control Release"},{"issue":"3","key":"362_CR93","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1021\/acs.bioconjchem.3c00041","volume":"34","author":"M Brouillard","year":"2023","unstructured":"Brouillard M, Kinet R, Joyeux M, Dehay B, Crauste-Manciet S, Desvergnes V. Modulating lysosomal pH through innovative multimerized succinic acid-based nucleolipid derivatives. Bioconjug Chem. 2023;34(3):572\u201380.","journal-title":"Bioconjug Chem"},{"issue":"5","key":"362_CR94","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.nano.2010.02.002","volume":"6","author":"B Semete","year":"2010","unstructured":"Semete B, Booysen L, Lemmer Y, Kalombo L, Katata L, Verschoor J, et al. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine. 2010;6(5):662\u201371.","journal-title":"Nanomedicine"},{"issue":"2","key":"362_CR95","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2217\/nnm.10.131","volume":"6","author":"SA Kulkarni","year":"2011","unstructured":"Kulkarni SA, Feng S-S. Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier. Nanomedicine. 2011;6(2):377\u201394.","journal-title":"Nanomedicine"},{"issue":"46","key":"362_CR96","doi-asserted-by":"publisher","first-page":"81001","DOI":"10.18632\/oncotarget.20944","volume":"8","author":"N Huang","year":"2017","unstructured":"Huang N, Lu S, Liu X-G, Zhu J, Wang Y-J, Liu R-T. PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering abeta generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer\u2019s disease mice. Oncotarget. 2017;8(46):81001\u201313.","journal-title":"Oncotarget"},{"issue":"2","key":"362_CR97","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/pharmaceutics14020276","volume":"14","author":"MC Operti","year":"2022","unstructured":"Operti MC, Bernhardt A, Sincari V, Jager E, Grimm S, Engel A, et al. Industrial scale manufacturing and downstream processing of PLGA-based nanomedicines suitable for fully continuous operation. Pharmaceutics. 2022;14(2):276.","journal-title":"Pharmaceutics"},{"issue":"32","key":"362_CR98","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1073\/pnas.1009485107","volume":"107","author":"MM Lipinski","year":"2010","unstructured":"Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, et al. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2010;107(32):14164\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"362_CR99","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1080\/15548627.2016.1239003","volume":"12","author":"M Bordi","year":"2016","unstructured":"Bordi M, Berg MJ, Mohan PS, Peterhoff CM, Alldred MJ, Che S, et al. Autophagy flux in CA1 neurons of Alzheimer hippocampus: increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy. 2016;12(12):2467\u201383.","journal-title":"Autophagy"},{"issue":"8","key":"362_CR100","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","volume":"432","author":"X Hou","year":"2020","unstructured":"Hou X, Watzlawik JO, Fiesel FC, Springer W. Autophagy in Parkinson\u2019s disease. J Mol Biol. 2020;432(8):2651\u201372.","journal-title":"J Mol Biol"},{"key":"362_CR101","doi-asserted-by":"publisher","first-page":"726479","DOI":"10.3389\/fncel.2021.726479","volume":"15","author":"CH Lo","year":"2021","unstructured":"Lo CH, Skarica M, Mansoor M, Bhandarkar S, Toro S, Pitt D. Astrocyte heterogeneity in multiple sclerosis: current understanding and technical challenges. Front Cell Neurosci. 2021;15:726479.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"362_CR102","doi-asserted-by":"publisher","first-page":"e200025","DOI":"10.1212\/NXI.0000000000200025","volume":"9","author":"D Pitt","year":"2022","unstructured":"Pitt D, Lo CH, Gauthier SA, Hickman RA, Longbrake E, Airas LM, et al. Toward precision phenotyping of multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022;9(6):e200025.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"362_CR103","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/jnen\/nlab122","volume":"81","author":"MN Shakir","year":"2022","unstructured":"Shakir MN, Dugger BN. Advances in deep neuropathological phenotyping of Alzheimer disease: past, present, and future. J Neuropathol Exp Neurol. 2022;81(1):2\u201315.","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-023-00362-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T20:02:07Z","timestamp":1686168127000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-023-00362-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["362"],"URL":"https:\/\/doi.org\/10.1186\/s40035-023-00362-0","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"5 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}